Edward J Dulac Iii Intellia Therapeutics, Inc. (NTLA) insider trading activity

Edward J Dulac Iii is EVP, Chief Financial Officer of Intellia Therapeutics, Inc.. Currently has a direct ownership of 113,524 shares of NTLA, which is worth approximately $851,430. The most recent transaction as insider was on Mar 01, 2025, when has been sold 47,200 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 114K

71.17% 3M change

n/a 12M change

Total Value Held $851,430

Edward J Dulac III Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Mar 01 2025	BUY Grant, award, or other acquisition	-	47,200 Added 29.37%	113,524 Common Stock
Jul 22 2024	BUY Grant, award, or other acquisition	-	66,324 Added 50.0%	66,324 Common Stock

Also insider at

FATE

FATE THERAPEUTICS INC Healthcare

Chief Financial Officer

EJD